Anti- Pneumocystis Activities of Aromatic Diamidoxime Prodrugs
- 1 March 1998
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 42 (3) , 666-674
Abstract
Aromatic dicationic compounds, such as pentamidine, have potent antimicrobial activities. Clinical use of these compounds has been restricted, however, by their toxicity and limited oral activity. A novel approach, using amidoxime derivatives as prodrugs, has recently been proposed to overcome these limitations. Although results were presented for amidoxime derivatives of only one diamidine, pentamidine, the authors in the original proposal claimed that amidoxime derivatives would work as effective prodrugs for all pharmacologically active diamidines. Nine novel amidoxime derivatives were synthesized and tested in the present study for activity against Pneumocystis carinii in corticosteroid-suppressed rats. Only three of the nine compounds had significant oral anti- Pneumocystis activity. The bisbenzamidoxime derivatives of three direct pentamidine analogs had excellent oral and intravenous activities and reduced acute host toxicity. These compounds are not likely candidates for future drug development, however, because they have chronic toxic effects and the active amidine compounds have multiple sites susceptible to oxidative metabolism, which complicates their pharmacology and toxicology. Novel diamidoximes from three other structural classes, containing different groups linking the cationic moieties, lacked significant oral or intravenous anti- Pneumocystis activity, even though the corresponding diamidines were very active intravenously. Both active and inactive amidoximes were readily metabolized to the corresponding amidines by cell-free liver homogenates. Thus, the amidoxime prodrug approach may provide a strategy to exploit the potent antimicrobial and other pharmacological activities of selected, but certainly not all, aromatic diamidines.Keywords
This publication has 47 references indexed in Scilit:
- Metabolism is an Important Route of Pentamidine Elimination in the Rat: Disposition of14C‐Pentamidine and Identification of Metabolites in Urine Using Liquid Chromatography‐Tandem Mass SpectrometryBasic & Clinical Pharmacology & Toxicology, 1995
- Fast atom bombardment tandem mass spectrometry of the anti‐parasitic agent pentamidine and its oxygenated metabolitesJournal of Mass Spectrometry, 1995
- Synthesis of dicationic diaryltriazines nucleic acid binding agentsEuropean Journal of Medicinal Chemistry, 1994
- Protease inhibitors suppress the in vitro and in vivo replication of rotavirus.Journal of Clinical Investigation, 1988
- Suppression of streptococcal cell wall–induced arthritis by a potent protease inhibitor, bis(5‐amidino‐2‐benzimidazolyl)methaneArthritis & Rheumatism, 1988
- Pentamidine IsethionateDrugs, 1987
- Novel bis(benzamidino) compounds with an aromatic central link. Inhibitors of thrombin, pancreatic kallikrein, trypsin, and complementJournal of Medicinal Chemistry, 1976
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- New aromatic diamidines with central .alpha.-oxyalkane or .alpha.,.omega.-dioxyalkane chains. Structure-activity relations for the inhibition of trypsin, pancreatic kallikrein, and thrombin and for the inhibition of the overall coagulation processJournal of Medicinal Chemistry, 1975
- Experimental chemotherapy of typhus Anti-rickettsial action of p -sulphonamidobenzamidine and related compoundsProceedings of the Royal Society of London. B. Biological Sciences, 1946